ChemPartner PharmaTech Co.,Ltd. (SZSE: 300149)
Health Care · Biotechnology · CN
CN¥9.90
+2.59% today · -15.5% 1Y
ChemPartner PharmaTech Co.,Ltd. (SZSE: 300149) operates in the Biotechnology industry within the Health Care sector. The company is valued at $745.31M.
Over the last twelve months the share price has lost 15.5%, trading between 7.22 and 14.23.
Tweenvest scores ChemPartner PharmaTech Co.,Ltd. across four factors: quality 63/100, value 35/100, growth 21/100. Its strongest factor is quality.
300149 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $745.31M
- Revenue (TTM)
- $171.27M
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- CN¥14.23
- 52-week low
- CN¥7.22
- Avg volume (3M)
- —
- Shares outstanding
- 504.99M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gyre Therapeutics, Inc.NasdaqCM: GYRE | $753.90M | $6.76 | -4.92% |
| JS Link, Inc.KOSDAQ: A127120 | $753.50M | ₩29,200.00 | -8.18% |
| Shenzhen Weiguang Biological Products Co., Ltd.SZSE: 002880 | $751.63M | CN¥22.23 | +3.35% |
| Qurient Co., Ltd.KOSDAQ: A115180 | $748.15M | ₩24,750.00 | +9.51% |
| Achieve Life Sciences, Inc.NasdaqCM: ACHV | $745.01M | $7.19 | -0.69% |
| Abbisko Cayman LimitedSEHK: 2256 | $739.95M | HK$8.75 | -2.34% |
| Solid Biosciences Inc.NasdaqGS: SLDB | $734.49M | $6.82 | -0.44% |
| Verastem, Inc.NasdaqCM: VSTM | $734.47M | $8.11 | -1.88% |
Figures last refreshed Oct 4, 2026.